Provided by Tiger Trade Technology Pte. Ltd.

Hepion Pharmaceuticals, Inc.

0.0500
-0.0010-1.96%
Volume:2.13K
Turnover:106.19
Market Cap:581.02K
PE:-0.06
High:0.0500
Open:0.0500
Low:0.0500
Close:0.0510
52wk High:0.9890
52wk Low:0.0330
Shares:11.62M
Float Shares:11.62M
Volume Ratio:0.19
T/O Rate:0.02%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.8800
EPS(LYR):-107.3480
ROE:-2058.63%
ROA:-100.37%
PB:0.60
PE(LYR):0.00

Loading ...

Feb 09, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 28, 2021

Major Issues Report

8-K - Current report
Jan 20, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 19, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Jan 07, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 05, 2021

Major Issues Report

8-K - Current report
Dec 29, 2020

Major Issues Report

8-K - Current report
Dec 28, 2020

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Dec 22, 2020

Major Issues Report

8-K - Current report
Dec 10, 2020

Major Issues Report

8-K - Current report
Dec 09, 2020

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Dec 02, 2020

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Dec 02, 2020

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Dec 02, 2020

Major Issues Report

8-K - Current report
Nov 27, 2020

Major Issues Report

8-K - Current report
Nov 20, 2020

Correspondence

CORRESP [Cover] - Correspondence
Nov 20, 2020

Correspondence

CORRESP [Cover] - Correspondence
Nov 20, 2020

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Nov 20, 2020

Major Issues Report

8-K - Current report
Nov 18, 2020

[Supp]Public Prospectus

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses